142 related articles for article (PubMed ID: 20204305)
1. The effect of siRNA-Egr-1 and camptothecin on growth and chemosensitivity of breast cancer cell lines.
Parra E; Ferreira J
Oncol Rep; 2010 Apr; 23(4):1159-65. PubMed ID: 20204305
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional targeting of human liver carboxylesterase (hCE1m6) and simultaneous expression of anti-BCRP shRNA enhances sensitivity of breast cancer cells to CPT-11.
Mishra MN; Vangara KK; Palakurthi S
Anticancer Res; 2014 Nov; 34(11):6345-51. PubMed ID: 25368234
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of Egr-1 by siRNA inhibits growth of human prostate carcinoma cell line PC-3.
Parra E; Ortega A; Saenz L
Oncol Rep; 2009 Dec; 22(6):1513-8. PubMed ID: 19885607
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study.
Tesauro C; Simonsen AK; Andersen MB; Petersen KW; Kristoffersen EL; Algreen L; Hansen NY; Andersen AB; Jakobsen AK; Stougaard M; Gromov P; Knudsen BR; Gromova I
BMC Cancer; 2019 Nov; 19(1):1158. PubMed ID: 31783818
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.
Liu W; Zhang R
Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of the c-Jun-N-terminal kinase expression by siRNA inhibits MCF-7 breast carcinoma cell line growth.
Parra E; Ferreira J
Oncol Rep; 2010 Nov; 24(5):1339-45. PubMed ID: 20878129
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Egr-1 by siRNA in prostate carcinoma cell lines is associated with decreased expression of AP-1 and NF-κB.
Parra E; Ferreira J; Saenz L
Int J Mol Med; 2011 Nov; 28(5):847-53. PubMed ID: 21743958
[TBL] [Abstract][Full Text] [Related]
9. Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.
Shamanna RA; Lu H; Croteau DL; Arora A; Agarwal D; Ball G; Aleskandarany MA; Ellis IO; Pommier Y; Madhusudan S; Bohr VA
Oncotarget; 2016 Mar; 7(12):13269-84. PubMed ID: 26959889
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of UbcH10 enhances the chemosensitivity of dual drug resistant breast cancer cells to epirubicin and docetaxel.
Wang C; Pan YH; Shan M; Xu M; Bao JL; Zhao LM
Int J Mol Sci; 2015 Mar; 16(3):4698-712. PubMed ID: 25739083
[TBL] [Abstract][Full Text] [Related]
11. Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU.
Samson AAS; Park S; Kim SY; Min DH; Jeon NL; Song JM
J Liposome Res; 2019 Mar; 29(1):44-52. PubMed ID: 29262741
[TBL] [Abstract][Full Text] [Related]
12. Reduced camptothecin sensitivity of estrogen receptor-positive human breast cancer cells following exposure to di(2-ethylhexyl)phthalate (DEHP) is associated with DNA methylation changes.
Chou CK; Huang HW; Yang CF; Dahms HU; Liang SS; Wang TN; Kuo PL; Hsi E; Tsai EM; Chiu CC
Environ Toxicol; 2019 Apr; 34(4):401-414. PubMed ID: 30720231
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
Gupta M; Fan S; Zhan Q; Kohn KW; O'Connor PM; Pommier Y
Clin Cancer Res; 1997 Sep; 3(9):1653-60. PubMed ID: 9815856
[TBL] [Abstract][Full Text] [Related]
14. Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit.
Guo J; Verma UN; Gaynor RB; Frenkel EP; Becerra CR
Clin Cancer Res; 2004 May; 10(10):3333-41. PubMed ID: 15161687
[TBL] [Abstract][Full Text] [Related]
15. siRNA-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells.
Karami H; Baradaran B; Esfahani A; Estiar MA; Naghavi-Behzad M; Sakhinia M; Sakhinia E
Asian Pac J Cancer Prev; 2013; 14(12):7719-24. PubMed ID: 24460358
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells.
Promkan M; Liu G; Patmasiriwat P; Chakrabarty S
Int J Cancer; 2009 Dec; 125(12):2820-8. PubMed ID: 19551867
[TBL] [Abstract][Full Text] [Related]
17. [siRNA-cyclin D1 inhibit cell proliferation in breast cancer MCF-7 cell line].
Jiang L; Chen RS; Li JC
Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Apr; 39(2):118-22. PubMed ID: 16944582
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of p21Waf1/Cip1 and JNK with costimulation of prostate cancer cell activation by an siRNA Egr-1 inhibitor.
Parra E; Gutiérrez L; Ferreira J
Oncol Rep; 2013 Aug; 30(2):911-6. PubMed ID: 23715767
[TBL] [Abstract][Full Text] [Related]
19. Noxa/Mcl-1 balance regulates susceptibility of cells to camptothecin-induced apoptosis.
Mei Y; Xie C; Xie W; Tian X; Li M; Wu M
Neoplasia; 2007 Oct; 9(10):871-81. PubMed ID: 17971907
[TBL] [Abstract][Full Text] [Related]
20. [Effects of RNA interference on epidermal growth factor receptor expression in breast cancer cells: a study in tumor-bearing nude mice].
Wu WD; Fang CH; Yang ZX
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):60-4. PubMed ID: 18227029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
